SF3B1 and myeloproliferative disorder: Additional criteria for the diagnosis of MDS/MPN-RS-T include the presence of SF3B1 mutations with ≥15% ring sideroblasts and no prior history of MDS or MPN, with the exception of MDS-RS [11].